Evergreen Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Buy |
33,472
+9,763
| +41% | +$682K | 0.07% | 243 |
|
|
2025
Q1 | $1.74M | Buy |
23,709
+155
| +0.7% | +$11.4K | 0.06% | 268 |
|
|
2024
Q4 | $1.54M | Buy |
23,554
+1,857
| +9% | +$122K | 0.05% | 289 |
|
|
2024
Q3 | $1.69M | Buy |
21,697
+1,466
| +7% | +$114K | 0.06% | 273 |
|
|
2024
Q2 | $1.58M | Buy |
20,231
+1,270
| +7% | +$99K | 0.06% | 262 |
|
|
2024
Q1 | $1.28M | Buy |
18,961
+265
| +1% | +$18K | 0.05% | 270 |
|
|
2023
Q4 | $1.26M | Buy |
18,696
+797
| +4% | +$53.7K | 0.05% | 271 |
|
|
2023
Q3 | $1.21M | Sell |
17,899
-835
| -4% | -$56.5K | 0.05% | 268 |
|
|
2023
Q2 | $1.34M | Buy |
18,734
+1,655
| +10% | +$118K | 0.06% | 254 |
|
|
2023
Q1 | $1.19M | Buy |
17,079
+463
| +3% | +$32.1K | 0.05% | 266 |
|
|
2022
Q4 | $1.13M | Buy |
16,616
+188
| +1% | +$12.7K | 0.05% | 265 |
|
|
2022
Q3 | $901K | Buy |
16,428
+798
| +5% | +$43.8K | 0.05% | 269 |
|
|
2022
Q2 | $1.03M | Buy |
15,630
+1,688
| +12% | +$112K | 0.05% | 247 |
|
|
2022
Q1 | $925K | Buy |
13,942
+1,804
| +15% | +$120K | 0.04% | 290 |
|
|
2021
Q4 | $707K | Buy |
12,138
+1,981
| +20% | +$115K | 0.03% | 327 |
|
|
2021
Q3 | $610K | Buy |
10,157
+1,764
| +21% | +$106K | 0.03% | 334 |
|
|
2021
Q2 | $503K | Buy |
8,393
+1,494
| +22% | +$89.5K | 0.02% | 339 |
|
|
2021
Q1 | $343K | Buy |
6,899
+2,160
| +46% | +$107K | 0.02% | 368 |
|
|
2020
Q4 | $237K | Buy |
4,739
+142
| +3% | +$7.1K | 0.01% | 384 |
|
|
2020
Q3 | $252K | Buy |
4,597
+404
| +10% | +$22.1K | 0.02% | 349 |
|
|
2020
Q2 | $222K | Buy |
+4,193
| New | +$222K | 0.02% | 345 |
|
|
2020
Q1 | – | Sell |
-5,175
| Closed | -$258K | – | 379 |
|
|
2019
Q4 | $258K | Buy |
5,175
+272
| +6% | +$13.6K | 0.02% | 372 |
|
|
2019
Q3 | $219K | Buy |
+4,903
| New | +$219K | 0.02% | 376 |
|
|
2019
Q1 | – | Sell |
-7,139
| Closed | -$271K | – | 408 |
|
|
2018
Q4 | $271K | Buy |
+7,139
| New | +$271K | 0.03% | 288 |
|